The putative role of cytokines in the induction of primary anti-phospholipid syndrome in mice
- 1 November 1992
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 90 (2) , 266-270
- https://doi.org/10.1111/j.1365-2249.1992.tb07940.x
Abstract
SUMMARY: Antiphospholipid syndrome (APLS) is characterized by thrombocytopenia, thromboembolic phenomena and recurrent fetal loss, associated with anti-cardiolipin antibodies (ACA) and/or lupus anticoagulant. The syndrome may be primary or may be associated with other conditions such as systemic lupus erythematosus (SLE). In this study we induced primary APLS following immunization of BALB/c mice with a human monoclonal ACA (H-3). Analysis of the cytokine profile of the mice with experimental APLS indicated low production of IL-2, IL-3 and granulocyte-macrophage colony-stimulating factor (GM-CSF) by concanavalin A (Con A)-slimulated splenocytes of H-3 immunized mice. It seems that the low levels of IL-3 and GM-CSF have a potential role in the fetal loss of the APLS. Whatever the mechanism of IL-3 and GM-CSF in preventing fetal loss, these results may have therapeutic bearing on the reproductive outcome in women and other species with APLS.Keywords
This publication has 17 references indexed in Scilit:
- The cytokine bassi for cross-talk between the maternal immune and reproductive systemsCurrent Opinion in Immunology, 1990
- Antiphospholipid antibodies: more than just a disease marker?Immunology Today, 1990
- The effect of the immunomodulator agent AS101 on interleukin-2 production in systemic lupus erythematosus (SLE) induced in mice by a pathogenic anti-DNA antibodyClinical and Experimental Immunology, 1990
- The “Primary” Antiphospholipid SyndromeMedicine, 1989
- Effects of Lymphokines and Immune Complexes on Murine Placental Cell Growth in Vitro1Biology of Reproduction, 1989
- Rheumatoid arthritis: An editorial perspective based on cytokine imbalanceJournal of Autoimmunity, 1988
- Deficient phytohemagglutinin‐induced interleukin‐2 activity in patients with inactive systemic lupus erythematosus is correctable by the addition of phorbol myristate acetateArthritis & Rheumatism, 1988
- Soluble interleukin‐2 receptors in systemic lupus erythematosusArthritis & Rheumatism, 1988
- Production of autoantibodies by human-human hybridomas.Journal of Clinical Investigation, 1982
- The cloning of normal “Mast” cells in tissue cultureJournal of Cellular and Comparative Physiology, 1965